发明名称 AQUEOUS LIQUID PREPARATION COMPRISING GATIFLOXACIN.
摘要 <p>Disclosed is an aqueous liquid preparation comprising (A) gatifloxacin, a pharmacologically acceptable salt thereof, or a hydrate of gatifloxacin or the salt, (B) hyaluronic acid or a pharmacologically acceptable salt thereof, and (C) a polyhydric alcohol. The aqueous liquid preparation is an ophthalmic aqueous liquid preparation excellent in the retention of gatifloxacin in a tear fluid and the penetration of gatifloxacin into an aqueous humor and a conjunctiva. Disclosed is an aqueous liquid preparation comprising (A) gatifloxacin, a pharmacologically acceptable salt thereof, or a hydrate of gatifloxacin or the salt, (B) hyaluronic acid or a pharmacologically acceptable salt thereof, and (C) a polyhydric alcohol. The aqueous liquid preparation is an ophthalmic aqueous liquid preparation excellent in the retention of gatifloxacin in a tear fluid and the penetration of gatifloxacin into an aqueous humor and a conjunctiva. Disclosed is a polycarbonate resin composition containing a glass filler, which is excellent in transparency, strength and heat resistance, while having high flame retardancy. Also disclosed is a polycarbonate resin molded article obtained by molding this resin composition. Specifically disclosed is a flame-retardant polycarbonate resin composition containing a combination of (A) 55-95% by mass of an aromatic polycarbonate resin and (B) 45-5% by mass of a glass filler having a refractive index difference of 0.002 or less from the aromatic polycarbonate resin, and further containing per 100 parts by mass of the combination, (C) 0.05-2.0 parts by mass of a silicone compound having a reactive functional group and (D) 0.03-0.4 part by mass of an organic alkali metal salt compound and/or an organic alkaline earth metal salt compound. Also disclosed is a polycarbonate resin molded article having a thickness of 0.3-10 mm which is obtained by molding the composition.</p>
申请公布号 MX2009003878(A) 申请公布日期 2009.09.15
申请号 MX20090003878 申请日期 2007.10.11
申请人 SENJU PHARMACEUTICAL CO., LTD. 发明人 SAWA, SHIROU
分类号 A61K31/496;A61K9/08;A61K47/10;A61K47/36;A61P27/02;A61P31/04 主分类号 A61K31/496
代理机构 代理人
主权项
地址